Genetic risk assessment towards warfarin application: Saudi Arabia study with a potential to predict and prevent side effects

Warfarin doses are greatly affected by polymorphism altering cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase complex subunit 1 (VKORC1) gene. This study evaluated the prevalence of alleles (either single or double) and carriers of single nucleotide polymorphisms (SNPs) in both genotypes...

Descripción completa

Detalles Bibliográficos
Autor principal: Al-Saikhan, Fahad I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933267/
https://www.ncbi.nlm.nih.gov/pubmed/31889870
http://dx.doi.org/10.1016/j.sjbs.2019.11.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933267/
https://www.ncbi.nlm.nih.gov/pubmed/31889870
http://dx.doi.org/10.1016/j.sjbs.2019.11.007

Ejemplares similares